Initially, we assessed the mRNA expression levels of SYVN1 in primary GCs from patients with PCOS and identified that SYVN1 levels were significantly downregulated in PCOS patient cells (n = 30) when compared with control samples (Figure 1(a)). This evidence concerns the gene SYVN1 and polycystic ovary syndrome.